IBEX Ltd Chief Operating Officer David Martin Afdahl reported a routine tax-related share disposition. On July 1, 2026, 1,138 common shares were withheld by IBEX to cover his tax liability from the vesting of 2,310 restricted stock units. The footnote clarifies that no shares were sold on the market to satisfy this obligation. After this withholding, Afdahl directly owned 156,164 IBEX common shares.
IBEX Ltd Chief Legal Officer Christina Alice Trofimuk-O'Connor reported a tax-related share disposition. On July 1, 2026, 700 common shares were withheld by IBEX at $31.60 per share to cover taxes on the vesting of 2,310 restricted stock units. According to the filing, no shares were sold to the market, and she now directly holds 35,035 common shares.
IBEX Ltd reported a routine insider transaction involving Chief Sales and CS Officer Bruce Neil Dawson. On July 1, 2026, 886 common shares were withheld by the company at $31.60 per share to cover tax obligations arising from the vesting of 2,022 restricted stock units. The footnote clarifies that no shares were sold in the market to satisfy this tax liability. After this tax-withholding disposition, Dawson directly holds 61,009 common shares.
IBEX Ltd reported an insider transaction by Chief Sales/Marketing Officer Julie K. Casteel. On June 11, 2026, she completed an open-market sale of 3,600 Common Shares at a weighted average price of $30.6065 per share. After this sale, she directly holds 117,594 Common Shares. The sale was executed in multiple trades, with individual prices ranging from $30.465 to $30.78, and the weighted average price aggregates those trades.
IBEX submitted a Form 144 notice listing common stock under a "Securities To Be Sold" section and records of broker activity. The excerpt shows three open market purchase entries dated 12/17/2021 (1,600 shares), 12/20/2021 (896 shares) and 12/22/2021 (1,104 shares).
IBEX Ltd director Patrick McGinnis sold shares in a routine insider transaction. On May 28, 2026, he completed an open-market sale of 1,030 Common Shares at $31.69 per share. After this sale, he continues to hold 5,833 Common Shares directly.
IBEX Ltd Chief Financial Officer Taylor C. Greenwald reported two share transactions in Common Shares. On May 22, 2026, he sold 964 shares in an open-market sale at $32.02 per share and acquired 3,333 shares from earned performance-based stock units. After these transactions, he directly owned 62,230 Common Shares.
IBEX Limited announced that its board of directors has authorized a share repurchase program allowing the company to buy back up to $20 million of its common stock. The program begins on May 14, 2026 and may run for up to one year.
Repurchases may occur through open market purchases, privately negotiated deals, block trades, or other lawful methods, subject to market conditions and compliance with SEC Rules 10b-18 and 10b5-1. The company plans to fund repurchases using its existing cash balance and free cash flow. The board may adjust, suspend, or discontinue the program at any time, and IBEX is not obligated to repurchase a specific number of shares.
IBEX Ltd Chief Executive Officer Robert Thomas Dechant sold 7,800 common shares in an open-market transaction. The shares were sold at a weighted average price of $30.4996 per share, with individual trades executed between $30.37 and $30.88. After this sale, Dechant directly holds 285,606 IBEX common shares.